Caris Life Sciences

199 articles with Caris Life Sciences

• Caris Life Sciences Raises $310 Million in Growth Capital from a Broad Syndicate of Leading Investors

  10/27/2020

  The financing includes a $235 million equity investment co-led by Highland Capital Management and Coatue; Sixth Street participates in equity round and provides $75 million in debt financing

• 

  Caris Life Sciences Secures $310 Million to Advance Precision Medicine Toolset

  10/27/2020

  Molecular science company Caris Life Sciences secured $310 million in growth capital that will be used to expand its presence in precision medicine in oncology.

• Winship Cancer Institute of Emory University Joins Caris' Precision Oncology Alliance

  10/20/2020

  Caris' collaborative network focused on expanding the application of precision medicine in oncology supports Winship's enterprising approach to research leading to transformative discoveries in cancer care and treatment

• Caris Life Sciences Launches CODEai - Real-World Clinico-Genomic Data Platform Powered by Artificial Intelligence

  10/13/2020

  The most comprehensive data solution in the industry, comprised of over 215,000 cases of real-world patient records with integrated molecular and clinical outcomes data, offers an unmatched resource for developing a better understanding of the unique molecular mechanisms of cancer

• Caris Life Sciences Appoints Brian Lamon, Ph.D., as Chief Business Officer, Head of BioPharma Business Development

  10/6/2020

  Lamon to oversee business development strategy and execution, and brings over 15 years of pharmaceutical and academia experience to the company

• New England Cancer Specialists Joins Caris Precision Oncology Alliance

  9/29/2020

  Caris' collaborative network focused on expanding the application of precision medicine in oncology welcomes New England's largest medical oncology group

• Caris Precision Oncology Alliance Welcomes UT Southwestern Medical Center

  9/22/2020

  Dallas-based UT Southwestern Medical Center's Simmons Cancer Center, one of the elite centers in the country for patient care, research and education joins Caris' best-in-class collaborative research network focused on expanding the application of precision medicine in oncology

• Caris Life Sciences to Present New Ovarian Cancer Research at ESMO Virtual Congress 2020

  9/15/2020

  Additional research will highlight findings in colorectal and gastrointestinal cancers that could impact treatment decisions for patients

• Caris Life Sciences Announces Participation in the 18th Annual Morgan Stanley Global Healthcare Conference

  9/9/2020

  Brian J. Brille to present a fireside chat covering molecular science and precision medicine.

• Penn State Cancer Institute Joins Caris Life Sciences' Precision Oncology Alliance

  8/25/2020

  Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced that Penn State Cancer Institute has joined its Precision Oncology Alliance™.

• Caris Life Sciences Partners with Elevation Oncology to Advance Enrollment in Phase 2 Trial of Patients with Solid Tumors Harboring NRG1 Gene Fusions

  8/11/2020

  Partnership explores innovative models for real-time identification, patient referral and enrollment of patients with solid tumors with a rare gene fusion

• Caris Precision Oncology Alliance Welcomes Montefiore Health System

  7/21/2020

  Montefiore Health System becomes the 39th member of the Caris collaborative network focused on expanding the application of precision medicine in oncology

• Caris Life Sciences Showcases Data on KRAS Mutations in Patients With Non-Small Cell Lung and Pancreatic Cancer at ASCO20 Virtual Scientific Program

  5/29/2020

  The combination of DNA sequencing and whole transcriptome sequencing provides critical insights that can guide treatment decisions across a range of cancers

• Rutgers Cancer Institute of New Jersey Joins Caris Life Sciences' Precision Oncology Alliance

  5/19/2020

  New Jersey's only NCI-designated Comprehensive Cancer Center becomes the 37th member of Caris' collaborative network focused on expanding the application of precision medicine in cancer treatment

• Caris Life Sciences to Present Data Spotlighting Clinical Impact of Precision Medicine in ASCO20 Virtual Scientific Program

  5/11/2020

  Data from 14 studies to highlight role of company's portfolio of precision medicine technologies in guiding treatment decisions for patients with cancer across tumor types

• Caris Life Sciences Submits Two PMA Applications to the FDA for Whole Exome and Whole Transcriptome Sequencing

  4/28/2020

  Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced the submission of two Pre-Market Approval applications for MI Exome™ CDx and MI Transcriptome™ CDx to the U.S. Food and Drug Administration.

• Caris Life Sciences Launches Whole Exome Sequencing with MI Exome

  4/22/2020

  The most comprehensive suite of molecular testing in the industry includes a new whole exome sequencing (DNA) assay complementing the Company's breakthrough whole transcriptome sequencing (RNA) performed on every patient

• Caris Life Sciences Appoints Dr. Chadi Nabhan as Chairman of Precision Oncology Alliance

  4/14/2020

  Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced Chadi Nabhan, MD, MBA, FACP has been appointed Chairman of its Precision Oncology Alliance™.

• Caris Life Sciences Launches MI FOLFOXai, Improving Overall Survival by 50% for Metastatic Colorectal Cancer Patients

  3/31/2020

  First AI-powered FOLFOX predictor to guide first-line metastatic colorectal cancer treatment

• Caris Life Sciences to Present at Cowen and Company 40th Annual Health Care Conference

  2/19/2020

  IRVING, Texas , Feb. 19, 2020 /PRNewswire/ -- Caris Life Sciences ® , a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that Brian Brille , Vice Chairman of the Company, will present at the Cowen and Company 40 th Annual Health Care Conference on Tuesday, March 3, 2020 , at 9:30 a.m. Eastern time . The confe